Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its subsidiary, Oravax Medical Inc., reported…
Continue Reading
Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine